文献速递重症综合管理与镇静镇痛儿科与产科急症

基于适配体的多重蛋白质组学方法识别儿童脓毒症患者血清蛋白变化

Serum Protein Changes in Pediatric Sepsis Patients Identified With an Aptamer-Based Multiplexed Proteomic Approach.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在40例临床脓毒症与30例心脏术后全身炎症对照儿童中,适配体蛋白质组学检出111种差异表达血清蛋白,可用于区分脓毒症与非感染性全身炎症。

该回顾性观察性队列研究在Seattle Children's Hospital的PICU和心脏ICU纳入40例临床脓毒症儿童与30例心脏体外循环术后(感染阴性全身炎症对照)儿童,用适配体多重蛋白质组学平台检测1,305种蛋白质。35例脓毒症与28例对照的血清样本可供筛查,线性模型与Boruta决策树分析共发现111种蛋白在两组间显著差异表达,其中55种曾在脓毒症患者中被报道;加权基因共表达网络分析识别出76种与临床脓毒症特征高度相关的蛋白,其中27种此前未在脓毒症中报道。作者结论认为这些血清蛋白变化有助于区分脓毒症与非感染性全身炎症。

要点

  • 研究纳入40例临床脓毒症儿童与30例心脏体外循环术后感染阴性全身炎症对照儿童,35例脓毒症和28例对照的血清样本可用于蛋白质组学筛查。
  • 适配体平台检测1,305种蛋白质,脓毒症组与对照组间共111种蛋白显著差异表达,其中55种此前已在脓毒症患者中报道。
  • 加权基因共表达网络分析识别出76种与临床脓毒症特征高度相关的蛋白,其中27种此前未在脓毒症中报道。
  • 作者结论认为,适配体多重蛋白质组学检出的血清蛋白变化可用于区分脓毒症与非感染性全身炎症。

适用人群与场景

  • 脓毒症组:临床明确的脓毒症儿童,有 confirmed 或 suspected infection、两项或以上全身炎症反应综合征标准,且至少存在心血管和/或肺器官功能障碍。
  • 对照组:心脏体外循环术后即刻儿童(感染阴性全身炎症对照)。
  • 场景:Seattle Children's Hospital的PICU和心脏ICU。

诊断标准与关键阈值

  • 脓毒症组纳入标准: confirmed 或 suspected infection、两项或以上全身炎症反应综合征标准、至少心血管和/或肺器官功能障碍。

研究设计与关键结果

  • 研究类型:回顾性观察性队列研究;样本量:40例临床脓毒症儿童与30例心脏体外循环术后感染阴性全身炎症对照儿童;35例脓毒症和28例对照的血清样本可用于适配体蛋白质组学筛查。
  • 适配体平台检测1,305种蛋白质;采用线性模型(linear models for microarray data)和Boruta(决策树)R包分析,脓毒症组与对照组间共111种蛋白显著差异表达,其中55种此前已在脓毒症患者中报道。
  • 加权基因共表达网络分析识别出76种与临床脓毒症特征高度相关的蛋白,其中27种此前未在脓毒症中报道。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究所用适配体多重蛋白质组学方法检出的血清蛋白变化可用于区分脓毒症与非感染性全身炎症。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, is a leading cause of death and disability among children worldwide. Identifying sepsis in pediatric patients is difficult and can lead to treatment delay. Our objective was to assess the host proteomic response to infection utilizing an aptamer-based multiplexed proteomics approach to identify novel serum protein changes that might help distinguish between pediatric sepsis and infection-negative systemic inflammation and hence can potentially improve sensitivity and specificity of the diagnosis of sepsis over current clinical criteria approaches.

DESIGN: Retrospective, observational cohort study.

SETTING: PICU and cardiac ICU, Seattle Children's Hospital, Seattle, WA.

PATIENTS: A cohort of 40 children with clinically overt sepsis and 30 children immediately postcardiopulmonary bypass surgery (infection-negative systemic inflammation control subjects) was recruited. Children with sepsis had a confirmed or suspected infection, two or more systemic inflammatory response syndrome criteria, and at least cardiovascular and/or pulmonary organ dysfunction.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Serum samples from 35 of the sepsis and 28 of the bypass surgery subjects were available for screening with an aptamer-based proteomic platform that measures 1,305 proteins to search for large-scale serum protein expression pattern changes in sepsis. A total of 111 proteins were significantly differentially expressed between the sepsis and control groups, using the linear models for microarray data (linear modeling) and Boruta (decision trees) R packages, with 55 being previously identified in sepsis patients. Weighted gene correlation network analysis helped identify 76 proteins that correlated highly with clinical sepsis traits, 27 of which had not been previously reported in sepsis.

CONCLUSIONS: The serum protein changes identified with the aptamer-based multiplexed proteomics approach used in this study can be useful to distinguish between sepsis and noninfectious systemic inflammation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Shubin NJ, Navalkar K, Sampson D, et al. Serum Protein Changes in Pediatric Sepsis Patients Identified With an Aptamer-Based Multiplexed Proteomic Approach. Crit Care Med. 2020. PMID: 31714400. doi:10.1097/CCM.0000000000004083

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。